Fadaltran is an α2-adrenoreceptor antagonist. References: Chen Q, Yi B, Ma J, Ning J, Wu L, Ma D, Lu K, Gu J. α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury. Oncotarget. 2016 Aug 30;7(35):55990-56001. doi: 10.18632/oncotarget.10809. PubMed PMID: 27463003; PubMed Central PMCID: PMC5302891.

纯度：≥98%

CAS：1799809-36-1